| This article has been cited by |
| 1 | Biological treatments for obsessive-compulsive and related disorders | |
| Xenia Borue,Mehak Sharma,Robert Hudak |
| Journal of Obsessive-Compulsive and Related Disorders.2015;6()7 |
| [DOI] |
|
| 2 | Second Generation Antipsychotic-Induced Obsessive-Compulsive Symptoms in Schizophrenia: A Review of the Experimental Literature | |
| Trehani M. Fonseka,Margaret A. Richter,Daniel J. Müller |
| Current Psychiatry Reports.2014;16(11)7 |
| [DOI] |
|
| 3 | Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia | |
| Maria-Ioanna Stefanou,Debora Vittore,Ines Wolz,Stefan Klingberg,Dirk Wildgruber |
| Frontiers in Psychiatry.2020;11(11)7 |
| [DOI] |
|
| 4 | Amisulpride as Add-on Treatment for Resistant Obsessive-Compulsive Disorder | |
| Chanoch Miodownik,Joseph Bergman,Paul P. Lerner,Anatoly Kreinin,Vladimir Lerner |
| Clinical Neuropharmacology.2015;38(1)26 |
| [DOI] |
|
| 5 | Induced Obsessive Compulsive Symptoms (OCS) in schizophrenia patients under Atypical 2 Antipsychotics (AAPs): review and hypotheses | |
| Diane Grillault Laroche,Adeline Gaillard |
| Psychiatry Research.2016;246(1)119 |
| [DOI] |
|
| 6 | Fluoxetine Adjunctive Therapy for Obsessive-Compulsive Symptoms Associated With Olanzapine in Schizophrenic Patients | |
| Tiago Figueiredo,Daniel Segenreich,Paulo Mattos |
| Journal of Clinical Psychopharmacology.2016;36(4)389 |
| [DOI] |
|
| 7 | Obsessive–Compulsive Disorder | |
| Gyula Bokor,Peter D. Anderson |
| Journal of Pharmacy Practice.2014;27(2)116 |
| [DOI] |
|
